about
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience.A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 studyA phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients.Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study.A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study.Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results.Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02.
P50
Q33302879-BFFEEF97-0440-4FEB-A52E-5389576073F3Q33392436-BEBC0FAE-B4E3-4B21-8921-B3B525BCE627Q33416656-0C6FD1D1-88A6-4F99-BCDD-284085504B4EQ33609532-867E78A0-91FE-4CE4-BB66-36EEADAF2640Q35542516-D1D4DC45-96AD-4FCC-901D-37544929BCC0Q35602915-C31F275F-F18C-4042-AAD2-E6CF957AE7CAQ35669893-68CD4877-C5F9-4A9F-B420-FC5B5E8AF96AQ38381633-6E9A2815-BAAC-4067-B286-673BEC52E94EQ38409519-205E25CB-14CA-489D-A287-92FB71413FA3Q39062058-CC50B588-8C4C-43E9-898B-9071ECB2D5E7Q39485433-4C3CEFD9-04F5-499A-B50B-64EED466D4A0
P50
description
onderzoeker
@nl
name
Martine Escoffre-Barbe
@ast
Martine Escoffre-Barbe
@en
Martine Escoffre-Barbe
@es
Martine Escoffre-Barbe
@sl
type
label
Martine Escoffre-Barbe
@ast
Martine Escoffre-Barbe
@en
Martine Escoffre-Barbe
@es
Martine Escoffre-Barbe
@sl
prefLabel
Martine Escoffre-Barbe
@ast
Martine Escoffre-Barbe
@en
Martine Escoffre-Barbe
@es
Martine Escoffre-Barbe
@sl